| 查看: 427 | 回复: 0 | |||
[交流]
请问慢乙肝的病人敢用苯溴马隆吗
|
|
如题，病人别嘌醇0.1 bid 后尿酸仍在五百多，现在建议苯溴马隆口服，但是查了资料说赛诺菲已经在03年因为苯溴马隆的肝损召回了，没有这方面的经验，请指教。 http://apps.who.int/medicinedocs/en/d/Js4947e/1.4.html 这是WHO的关于苯溴马隆召回的材料。 BENZ-BROMARONE - Withdrawn due to reports of liver damage France. Sanofi-Synthélabo has withdrawn its hyperuricaemic product benzbromarone (Desuric) in France following reports of serious liver damage associated with the product's use. Benzbromarone (Desuric) has been marketed in France since 1976, but rare reports of serious cytolytic liver damage, including fatal cases and others requiring liver transplants, have led to an unfavourable benefit/risk ratio. The company has therefore decided to stop the marketing of this product in France and to recall all stocks. Reference: Chaibriant H. Stop marketing of proprietary medical product DESURIC (Rm) (benzbromarone), 22 Apr 2003. Available from URL: http://agmed.sante.gouv.fr |
回复此楼» 猜你喜欢
26申博----院士亲传弟子求收留
已经有14人回复
-
26申博自荐
已经有1人回复
-
急重症医学/创伤/烧伤/整形论文润色/翻译怎么收费?
已经有58人回复
-
美国俄亥俄州立大学 Dr. Gao 实验室诚招肿瘤免疫方向的博士后与技术员
已经有3人回复
-
请问哪位友友投稿过Journal for immunotherapy of cancer (JITC)?
已经有3人回复
-
26博士自荐
已经有56人回复
» 本主题相关商家推荐: (我也要在这里推广)
